SCHEMBL16620069

SCHEMBL16620069

O=C(Nc1cccc(Cl)c1)N[C@@H]1CCN(c2ccc3nncn3n2)C1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 5/20 0.77
CCNC P24863 4/20 0.72
EPHX2 P34913 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
EPHX1 P07099 1/20 0.48
TSHR P16473 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
PAK1 Q13153 1/20 0.47
CA12 O43570 7/20 0.47
CA1 P00915 7/20 0.47
CA2 P00918 7/20 0.47
CA4 P22748 7/20 0.47
CA7 P43166 7/20 0.47
CA9 Q16790 7/20 0.47
NTRK1 P04629 1/20 0.46
NTRK3 Q16288 1/20 0.46
NTRK2 Q16620 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16620195 1.00 CDK8 (0.77) CDK8CCNCEPHX2MEN1NPC1
SCHEMBL16620436 0.87 CDK8 (1.00) CDK8CCNCEPHX2MEN1KMT2A
SCHEMBL16620363 0.87 CDK8 (1.00) CDK8CCNCEPHX2MEN1KMT2A
SCHEMBL16620594 0.86 CDK8 (0.76) CDK8CCNCEPHX2NPC1TSHR
SCHEMBL16620598 0.86 CDK8 (0.76) CDK8CCNCEPHX2NPC1TSHR
SCHEMBL16620076 0.84 CDK8 (1.00) CDK8CCNCEPHX2CA12CA1
SCHEMBL16620435 0.84 CDK8 (1.00) CDK8CCNCEPHX2CA12CA1
SCHEMBL16620537 0.75 CDK8 (0.73) CDK8CCNCNTRK1NTRK3NTRK2
SCHEMBL16620539 0.75 CDK8 (0.73) CDK8CCNCNTRK1NTRK3NTRK2
SCHEMBL16620029 0.73 CDK8 (0.57) CDK8CCNCRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO claimed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
US-20150045255-A1 Endometrial Phase or Endometrial Cancer Biomarkers WALFISH, PAUL (CA) 2015-02-12 US disclosed